Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
LONDON, Nov 27 (Reuters) - Britain on Friday asked its medicine regulator to assess Oxford University and AstraZeneca's COVID-19 vaccine candidate for temporary supply, a step towards beginning a roll-out before the end of the year.AstraZeneca exp...
Read moreMOSCOW, Nov 26 (Reuters) - Developers of the Sputnik V COVID-19 vaccine said on Thursday that AstraZeneca should try combining its experimental shot with the Russian one to boost efficacy.Russia said its Sputnik V vaccine is 92% effective at prot...
Read more
UPDATE: AstraZeneca Says Its Vaccine Needs "Additional Study"
Read moreLONDON, Nov 26 (Reuters) - The British government's Chief Scientific Adviser Patrick Vallance said on Thursday the main point about the AstraZeneca vaccine against COVID-19 was that it worked, when asked about doubts that have been raised about th...
Read more"Additional Study" Needed For AstraZeneca Vaccine Says CEO
Read more(Adds AstraZeneca statement)Nov 26 (Reuters) - AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over th...
Read more(Adding details)Nov 26 (Reuters) - AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, its chief executive Pascal Soriot was quoted as saying on Thursday after questions over the results from its...
Read more(Adds details)Nov 26 (Reuters) - AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, its chief executive Pascal Soriot was quoted as saying on Thursday after questions over the results from its l...
Read more(Adding details throughout)Nov 26 (Reuters) - AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the...
Read moreLONDON MARKET CLOSE: FTSE Trails Peers Amid Thanksgiving Profit Taking
Read moreNov 26 (Reuters) - AstraZeneca Plc is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine, according to the company's Chief Executive Pascal Soriot, Bloomberg News reported on Thursday.Instead of adding the tria...
Read more(Adds details from news conference)ZURICH, Nov 26 (Reuters) - Swiss ski resorts can stay open for now as long as they have strict safety measures in place to limit the spread of the coronavirus, Health Minister Alain Berset said on Thursday.Neighb...
Read moreBy Caroline CopleyBERLIN, Nov 26 (Reuters) - Berlin is racing to open six mass vaccination centres capable of handling up to 4,000 people per day by mid-December, the project coordinator told Reuters on Thursday, as the city waits for authorities ...
Read moreBy MacDonald Dzirutwe and Alexander WinningJOHANNESBURG, Nov 26 (Reuters) - Mass vaccination against COVID-19 is unlikely to start in Africa until midway through next year and keeping vaccines cold could be a big challenge, the continent's disease...
Read moreUPDATE: AstraZeneca-Oxford 90% Vaccine Score Only In Younger Age Group
Read more
Last checked at